Bempedoic acid

Independent reference data for Bempedoic acid (CAS 738606-46-7), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Physicochemical values on record

Documented uses on record

Bempedoic acid is a prescription-only, once-daily oral tablet administered to reduce low-density lipoprotein cholesterol (LDL-C) levels. The drug works by inhibiting cholesterol synthesis in the same pathway as statins and has shown promising results in reducing the risks of cardiovascular diseases. Bempedoic acid is specifically effective for patients who require additional LDL-C reduction despite maximally tolerated statin therapy. In addition, bempedoic acid therapy provides a beneficial option for patients whoBreast Feeding; Lactation; Milk, Human; Anticholesteremic Agents; Hypolipidemic Agents; Enzyme Inhibitors

Synonyms and trade names

bempedoic acid; 738606-46-7; ETC-1002; 8-Hydroxy-2,2,14,14-tetramethylpentadecanedioic acid; Nexletol; ESP-55016; acido bempedoico; ETC1002; acide bempedoique; acidum bempedoicum; ETC 1002; ESP 55016; 1EJ6Z6Q368; Pentadecanedioic acid, 8-hydroxy-2,2,14,14-tetramethyl-; CHEBI:149601; DTXSID401027952

GHS hazard classification

Reported hazard statements	H302 (33.3%), H319 (33.3%), H372 (33.3%), H373 (33.3%)

H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]

H319 (33.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

What the public record says

Bempedoic acid · CAS 738606-46-7 · C19H36O5. UNII 1EJ6Z6Q368. Melting Point: 87-92.

Source: PubChem / Wikidata; the batch COA governs where values differ.